Status:
COMPLETED
Prospective Registry of European Hemophilia B Patients Receiving BeneFIX® for Usual Use
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Hemophilia B
Eligibility:
All Genders
Brief Summary
This is an open-label multi-center Registry in patients with hemophilia B receiving BeneFIX. All patients who begin treatment with BeneFIX in European Union countries, will be eligible for participati...
Eligibility Criteria
Inclusion
- Patients with Hemophilia B scheduled to begin treatment with BeneFIX are eligible for Registry enrollment
Exclusion
Key Trial Info
Start Date :
January 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
218 Patients enrolled
Trial Details
Trial ID
NCT00167973
Start Date
January 1 2002
End Date
June 1 2009
Last Update
May 26 2010
Active Locations (90)
Enter a location and click search to find clinical trials sorted by distance.
1
Vienna, Austria, 1090
2
Brussels, Belgium, 1020
3
Brussels, Belgium, 1090
4
Brussels, Belgium, 1200